Results 51 to 60 of about 684 (141)

MICROENCAPSULATION BISOPROLOL FUMARATE WITH EUDRAGIT E PO BY SOLVENT EVAPORATION METHOD

open access: yesInternational Journal of Applied Pharmaceutics
Objective: This study aimed to develop and optimize the microcapsule formula of bisoprolol fumarate-Eudragit EPO by double-emulsion solvent evaporation. Methods: The preparation of bisoprolol fumarate-Eudragit EPO microcapsule was done in three different ratios 1: 3 (F1), 1: 4 (F2), and 1: 5 (F3), followed by characterization of each of the ...
AZHOMA GUMALA   +3 more
openaire   +1 more source

DEVELOPMENT AND VALIDATION OF BISOPROLOL FUMARATE IN BULK AND PHARMACEUTICAL DOSAGE FORMS

open access: yes
UV Spectroscopy is a widely used analytical technique that involves the absorption of ultraviolet radiation by molecules, leading to electronic transitions. The aim of the presented work is to develop and validate a simple, rapid, accurate, precise and effective UV-spectroscopy method for the estimation of bisoprolol, an anti- hypertensive drug ...
openaire   +2 more sources

New Drugs: Bisoprolol fumarate [PDF]

open access: yesAustralian Prescriber, 2002
openaire   +1 more source

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF BISOPROLOL FUMARATE: A TECHNICAL REVIEW

open access: yes
Bisoprolol fumarate is a drug mainly used for the long-term treatment of high blood pressure. It works by reducing the heart rate and lowering the workload on the heart, which helps in controlling blood pressure with fewer breathing-related side effects.
openaire   +1 more source

Compounding and stability studies of liquid oral formulations of beta-blockers (bisoprolol, betaxolol, and nadolol) for paediatric patients. [PDF]

open access: yesJ Pharm Pharm Sci
Dubois L   +9 more
europepmc   +1 more source

Intravenous Tolvaptan Sodium Phosphate Can Fail to Improve Fluid Overload Due to Heart Failure in Patients With Chronic Kidney Disease: A Case Report. [PDF]

open access: yesPharmacol Res Perspect
Uno T   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy